XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
SVS Shares (as converted)
Share
Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Earnings (Deficit)
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2021   324,312,662        
Beginning balance at Dec. 31, 2021 $ 1,481,806   $ 1,535,765 $ 0 $ (55,235) $ 1,276
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   2,613,337        
Share-based compensation 36,664   36,664      
Issuance of shares in conjunction with acquisitions (in shares)   3,925,683        
Issuance of shares in conjunction with acquisitions 31,116   31,116      
Non-controlling interest adjustment for change in ownership (1,567)         (1,567)
Foreign currency translation adjustment 103     103    
Contingent consideration & other adjustments to purchase accounting (in shares)   5,310,540        
Contingent consideration & other adjustments to purchase accounting 44,935   44,935      
Net income (loss) (52,763)       (53,054) 291
Ending balance (in shares) at Sep. 30, 2022   336,162,222        
Ending balance at Sep. 30, 2022 1,540,294   1,648,480 103 (108,289) 0
Beginning balance (in shares) at Jun. 30, 2022   330,818,664        
Beginning balance at Jun. 30, 2022 1,548,725   1,614,021 0 (65,296) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   1,815,430        
Share-based compensation 12,399   12,399      
Issuance of shares in conjunction with acquisitions (in shares)   1,714,358        
Issuance of shares in conjunction with acquisitions 12,356   12,356      
Foreign currency translation adjustment 103     103    
Contingent consideration & other adjustments to purchase accounting (in shares)   1,813,770        
Contingent consideration & other adjustments to purchase accounting 9,704   9,704      
Net income (loss) (42,993)       (42,993)  
Ending balance (in shares) at Sep. 30, 2022   336,162,222        
Ending balance at Sep. 30, 2022 1,540,294   1,648,480 103 (108,289) 0
Beginning balance (in shares) at Dec. 31, 2022   339,983,374        
Beginning balance at Dec. 31, 2022 1,341,550   1,665,957 (8) (324,399) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   1,104,515        
Share-based compensation 9,391   9,391      
Issuance of shares to relieve liability obligations, net (in shares)   816,021        
Issuance of shares to relieve liability obligations, net 2,610   2,610      
Foreign currency translation adjustment (4)     (4)    
Contingent consideration & other adjustments to purchase accounting (in shares)   1,625,546        
Net income (loss) (40,062)       (40,140) 78
Ending balance (in shares) at Sep. 30, 2023   343,529,456        
Ending balance at Sep. 30, 2023 1,313,485   1,677,958 (12) (364,539) 78
Beginning balance (in shares) at Jun. 30, 2023   343,367,514        
Beginning balance at Jun. 30, 2023 1,326,344   1,673,049 (8) (346,697) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation (in shares)   161,942        
Share-based compensation 4,909   4,909      
Foreign currency translation adjustment (4)     (4)    
Net income (loss) (17,764)       (17,842) 78
Ending balance (in shares) at Sep. 30, 2023   343,529,456        
Ending balance at Sep. 30, 2023 $ 1,313,485   $ 1,677,958 $ (12) $ (364,539) $ 78